Plasma protein fraction. Product improvement studies

Area of Science:

• Biochemistry
• Pharmacology

Background:

• Sodium acetate is known to cause vasodilative effects.
• Existing plasma protein fraction (PPF) preparations may contain sodium acetate.
• Vasodilation can be an undesirable side effect in medical applications.

Purpose of the Study:

• To develop and evaluate improved plasma protein fraction (PPF) preparations.
• To substantially reduce or eliminate sodium acetate content in PPF.
• To mitigate the vasodilative effects associated with PPF.

Main Methods:

• Development of novel purification techniques for PPF.
• Chemical analysis to quantify sodium acetate levels.
• In vitro and/or in vivo studies to assess vasodilative potential.

Main Results:

• Successfully developed PPF preparations with significantly reduced sodium acetate.
• Demonstrated a marked decrease in vasodilative effects in the improved PPF.
• Characterized the biochemical properties of the enhanced PPF product.

Conclusions:

• The new PPF preparations are substantially free of sodium acetate.
• The improved product effectively minimizes associated vasodilative effects.
• This advancement offers a safer and more effective plasma protein fraction product.